Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Perea, Lídia
- dc.contributor.author Rodrigo-Troyano, Ana
- dc.contributor.author Cantó, Elisabet
- dc.contributor.author Domínguez Álvarez, Marisol
- dc.contributor.author Giner, Jordi
- dc.contributor.author Sanchez-Reus, Ferran
- dc.contributor.author Villar García, Judit
- dc.contributor.author Quero, Sara
- dc.contributor.author García-Nuñez, Marian
- dc.contributor.author Marín, Alicia
- dc.contributor.author Monsó Molas, Eduard
- dc.contributor.author Faner, Rosa
- dc.contributor.author García-Nuñez, Marian
- dc.contributor.author Vidal, Silvia
- dc.contributor.author Sibila, Oriol
- dc.date.accessioned 2020-06-19T07:06:41Z
- dc.date.available 2020-06-19T07:06:41Z
- dc.date.issued 2020
- dc.description.abstract Background: For still unclear reasons, chronic airway infection often occurs in patients with Chronic Obstructive Pulmonary Disease (COPD), particularly in those with more severe airflow limitation. Fatty-acid binding protein 4 (FABP4) is an adipokine involved in the innate immune response against infection produced by alveolar macrophages (Mɸ). We hypothesized that airway levels of FABP4 may be altered in COPD patients with chronic airway infection. Methods: In this prospective and controlled study we: (1) compared airway FABP4 levels (ELISA) in induced sputum, bronchoalveolar lavage fluid (BALF) and plasma samples in 52 clinically stable COPD patients (65.2 ± 7.9 years, FEV1 59 ± 16% predicted) and 29 healthy volunteers (55.0 ± 12.3 years, FEV1 97 ± 16% predicted); (2) explored their relationship with the presence of bacterial airway infection, defined by the presence of potentially pathogenic bacteria (PPB) at ≥103 colony-forming units/ml in BALF; (3) investigated their relationship with the quantity and proportion of Mɸ in BALF (flow cytometry); and, (4) studied their relationship with the severity of airflow limitation (FEV1), GOLD grade and level of symptoms (CAT questionnaire). Results: We found that: (1) airway levels of FABP4 (but not plasma ones) were reduced in COPD patients vs. controls [219.2 (96.0-319.6) vs. 273.4 (203.1-426.7) (pg/ml)/protein, p = 0.03 in BALF]; (2) COPD patients with airway infection had lower sputum FABP4 levels [0.73 (0.35-15.3) vs. 15.6 (2.0-29.4) ng/ml, p = 0.02]; (3) in COPD patients, the number and proportion of Mɸ were positively related with FABP4 levels in BALF; (4) BALF and sputum FABP4 levels were positively related with FEV1, negatively with the CAT score, and lowest in GOLD grade D patients. Conclusions: Airway FABP4 levels are reduced in COPD patients, especially in those with airway infection and more severe disease. The relationship observed between Mɸ and airway FABP4 levels supports a role for FABP4 in the pathogenesis of airway infection and disease severity in COPD.
- dc.format.mimetype application/pdf
- dc.identifier.citation Perea L, Rodrigo-Troyano A, Cantó E, Domínguez-Álvarez M, Giner J, Sanchez-Reus F, et al. Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity. Respir Res. 2020 Jan 13 ;21(1):21. DOI: 10.1186/s12931-020-1278-5
- dc.identifier.doi http://dx.doi.org/10.1186/s12931-020-1278-5
- dc.identifier.issn 1465-9921
- dc.identifier.uri http://hdl.handle.net/10230/45018
- dc.language.iso eng
- dc.publisher BioMed Central
- dc.rights Copyright © The Author(s). 2020. Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Bronchoalveolar lavage fluid
- dc.subject.keyword Chronic obstructive pulmonary disease
- dc.subject.keyword FABP4
- dc.subject.keyword Macrophages
- dc.title Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion